Acquisition by Smaldone Alsup Laurie of 4121 shares of Arvinas subject to Rule 16b-3
ARVN Stock | USD 17.89 0.34 1.94% |
About 51% of Arvinas' investors are presently thinking to get in. The analysis of overall sentiment of trading Arvinas stock suggests that some investors are interested at this time. Arvinas' investing sentiment overview a quick insight into current market opportunities from investing in Arvinas. Many technical investors use Arvinas stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Arvinas |
Filed transaction by Arvinas Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Arvinas' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Arvinas' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Arvinas Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Arvinas can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Arvinas Historical Investor Sentiment
Investor biases related to Arvinas' public news can be used to forecast risks associated with an investment in Arvinas. The trend in average sentiment can be used to explain how an investor holding Arvinas can time the market purely based on public headlines and social activities around Arvinas. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arvinas' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arvinas and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Arvinas news discussions. The higher the estimate score, the more favorable the investor's outlook on Arvinas.
Arvinas Maximum Pain Price Across April 17th 2025 Option Contracts
Arvinas' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Arvinas close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Arvinas' options.
Arvinas Fundamental Analysis
We analyze Arvinas' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arvinas using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arvinas based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Arvinas is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Arvinas Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arvinas stock to make a market-neutral strategy. Peer analysis of Arvinas could also be used in its relative valuation, which is a method of valuing Arvinas by comparing valuation metrics with similar companies.
Peers
Arvinas Related Equities
FHTX | Foghorn Therapeutics | 9.05 | ||||
GLUE | Monte Rosa | 7.68 | ||||
RVMD | Revolution Medicines | 5.25 | ||||
STOK | Stoke Therapeutics | 4.57 | ||||
KURA | Kura Oncology | 4.42 | ||||
IPSC | Century Therapeutics | 3.66 | ||||
BDTX | Black Diamond | 3.28 | ||||
KYMR | Kymera Therapeutics | 2.66 | ||||
CCCC | C4 Therapeutics | 2.51 | ||||
CRNX | Crinetics Pharmaceuticals | 2.23 | ||||
RARE | Ultragenyx | 2.19 | ||||
NRIX | Nurix Therapeutics | 1.88 | ||||
RLAY | Relay Therapeutics | 1.34 | ||||
PLRX | Pliant Therapeutics | 0.74 | ||||
STTK | Shattuck Labs | 5.30 |
Check out Arvinas Hype Analysis, Arvinas Correlation and Arvinas Performance. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.79) | Revenue Per Share | Quarterly Revenue Growth 1.96 | Return On Assets | Return On Equity |
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.